Stefan Carlsson

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Reducing MRI Use in Organized Prostate Cancer Testing Using Blood-based Biomarkers: The OPT Stockholm3 Study.

Reducing MRI Use in Organized Prostate Cancer Testing Using Blood-based Biomarkers: The OPT Stockholm3 Study.

Journal: European urology oncology

Published: May 19, 2026

First-in-human to proof-of-concept: why experimental medicine studies remain essential in human physiology and drug development.

First-in-human to proof-of-concept: why experimental medicine studies remain essential in human physiology and drug development.

Journal: Pflugers Archiv : European journal of physiology

Published: January 25, 2026

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study.

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study.

Journal: BJU international

Published: January 15, 2026

The Swedish national guidelines on prostate cancer: recurrent, metastatic and castration resistant disease.

The Swedish national guidelines on prostate cancer: recurrent, metastatic and castration resistant disease.

Journal: Scandinavian journal of urology

Published: December 11, 2025

A Randomised Clinical Trial Comparing Two Biopsy Templates and Follow-up Schedules for Men on Active Surveillance for Low-risk Prostate Cancer: SAMS.

A Randomised Clinical Trial Comparing Two Biopsy Templates and Follow-up Schedules for Men on Active Surveillance for Low-risk Prostate Cancer: SAMS.

Journal: European urology open science

Published: October 31, 2025

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Journal: European urology

Published: October 23, 2025

Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: nationwide population-based cohort study in Sweden.

Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: nationwide population-based cohort study in Sweden.

Journal: Scandinavian journal of urology

Published: September 20, 2025

Reply to Natália Dalsenter Avilez, Tomás Bernardo Costa Moretti, and Leonardo Oliveira Reis' Letter to the Editor re: Anna Lantz, Ying Li, Stefan Carlsson, et al. Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.004.

Reply to Natália Dalsenter Avilez, Tomás Bernardo Costa Moretti, and Leonardo Oliveira Reis' Letter to the Editor re: Anna Lantz, Ying Li, Stefan Carlsson, et al. Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.004.

Journal: European urology oncology

Published: August 18, 2025

The impact of short-term non-steroidal androgen antagonist therapy on PSMA expression and tumor cellularity studied with dynamic [68Ga]Ga-PSMA-11 PET/MR in hormone-sensitive prostate cancer patients, a preliminary longitudinal prospective study.

The impact of short-term non-steroidal androgen antagonist therapy on PSMA expression and tumor cellularity studied with dynamic [68Ga]Ga-PSMA-11 PET/MR in hormone-sensitive prostate cancer patients, a preliminary longitudinal prospective study.

Journal: EJNMMI research

Published: May 06, 2025

Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups.

Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups.

Journal: BJU international

Published: April 25, 2025

Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial.

Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial.

Journal: European urology oncology

Published: January 23, 2025

Patient- and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study.

Patient- and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study.

Journal: European urology oncology

Published: December 14, 2024

Showing 1-12 of 94

Last Updated: 09/26/2026